Pharmacogenetics and Genomics

MiRNA-139-3p inhibits malignant progression in urothelial carcinoma of the bladder via targeting KIF18B and inactivating Wnt/beta-catenin pathway

Pharmacogenetics and Genomics. 33(1):1-9, January 2023.

• Abstract
  Abstract
• Favorite
• PDF
• Permissions

• Buy